Evidence map›Paper›PMID 40983637›Full record

ArticleOncogene2025

Publisher Correction: NeuroD1 drives a KAT2A-FDFT1 signaling axis to promote cholesterol biosynthesis and hepatocellular carcinoma progression via histone H3K27 acetylation.

Zheng Wu, Wei Duan, Ying Xiong, Jingyi Liu, Xinpeng Wen, Fuqiang Zhao, Debing Xiang, Jian Wang, Vivi Kasim, Shourong Wu

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Oncogene, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Zheng WuKey Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering; Department of Oncology, Chongqing University Jiangjin Hospital, Chongqing University, Chongqing, China.ORCID http://orcid.org/0009-0003-6761-7857
Wei DuanKey Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering; Department of Oncology, Chongqing University Jiangjin Hospital, Chongqing University, Chongqing, China.
Ying XiongKey Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering; Department of Oncology, Chongqing University Jiangjin Hospital, Chongqing University, Chongqing, China.
Jingyi LiuKey Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering; Department of Oncology, Chongqing University Jiangjin Hospital, Chongqing University, Chongqing, China.
Xinpeng WenKey Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering; Department of Oncology, Chongqing University Jiangjin Hospital, Chongqing University, Chongqing, China.
Fuqiang ZhaoKey Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering; Department of Oncology, Chongqing University Jiangjin Hospital, Chongqing University, Chongqing, China.
Debing XiangKey Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering; Department of Oncology, Chongqing University Jiangjin Hospital, Chongqing University, Chongqing, China.
Jian WangKey Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering; Department of Oncology, Chongqing University Jiangjin Hospital, Chongqing University, Chongqing, China. wj929@cqu.edu.cn.
Vivi KasimKey Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering; Department of Oncology, Chongqing University Jiangjin Hospital, Chongqing University, Chongqing, China. vivikasim@cqu.edu.cn.ORCID http://orcid.org/0000-0001-9182-8230
Shourong WuKey Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering; Department of Oncology, Chongqing University Jiangjin Hospital, Chongqing University, Chongqing, China. shourongwu@cqu.edu.cn.ORCID http://orcid.org/0000-0001-9650-5465

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40983637

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.